A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response
Science Immunology · 26.01.2024 · 9 (91)
DOI: 10.1126/sciimmunol.adi2848 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 26.01.2024. Verfasst von David Wu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California, San Francisco, San Francisco, CA 94107, USA. Hauptthemen laut MEDLINE: Interleukin-17, Psoriasis. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NIAMS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Psoriasis vulgaris and other chronic inflammatory diseases improve markedly with therapeutic blockade of interleukin-23 (IL-23) signaling, but the genetic mechanisms underlying clinical responses remain poorly understood. Using single-cell transcriptomics, we profiled immune cells isolated from lesional psoriatic skin before and during IL-23 blockade. In clinically responsive patients, a psoriatic transcriptional signature in skin-resident memory T cells was strongly attenuated. In contrast, poorly responsive patients were distinguished by persistent activation of IL-17–producing T (T17) cells, a mechanism distinct from alternative cytokine signaling or resistance isolated to epidermal keratinocytes. Even in IL-23 blockade–responsive patients, we detected a recurring set of recalcitrant, disease-specific transcriptional abnormalities. This irreversible immunological state may necessitate ongoing IL-23 inhibition. Spatial transcriptomic analyses also suggested that successful IL-23 blockade requires dampening of >90% of IL-17–induced response in lymphocyte-adjacent keratinocytes, an unexpectedly high threshold. Collectively, our data establish a patient-level paradigm for dissecting responses to immunomodulatory treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of California, San Francisco, San Francisco, CA 94107, USA.
- Dermatology Service, San Francisco Veterans Administration Health Care System, San Francisco, CA 94121, USA.
- Department of Dermatology, Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710004, China.
- Dermatopathology Service, University of California, San Francisco, San Francisco, CA 94107, USA.
- Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
- Enable Medicine, Menlo Park, CA 94025, USA.
ORCID-Profile: David Wu, Ashley A Hailer, Sijia Wang, Abdullah El Kurdi, Ayano Kondo, Blaize D'Angio, Aaron Mayer, A Hunter Shain, Jaehyuk Choi, Gregory Simpson, Roy C Grekin, Roberto Ricardo-Gonzalez, Elizabeth Purdom, Jeffrey P North, Jeffrey B Cheng, Raymond J Cho
Förderung
- NIAMS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
Zitieren
APA
Wu, D., Hailer, A. A., Wang, S., Yuan, M., Chan, J., El Kurdi, A., Rahim, M., Kondo, A., Han, D., Ali, H., D'Angio, B., Mayer, A., Klufas, D., Kim, E., Shain, A. H., Choi, J., Bhutani, T., Simpson, G., Grekin, R. C., …, & Cho, R. J. (2024). A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Science Immunology, 9(91). https://doi.org/10.1126/sciimmunol.adi2848
Vancouver
Wu D, Hailer AA, Wang S, Yuan M, Chan J, El Kurdi A, et al. A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response. Science Immunology. 2024;9(91). doi:10.1126/sciimmunol.adi2848
BibTeX
@article{Wu2024,
author = {Wu, David and Hailer, Ashley A and Wang, Sijia and Yuan, Michelle and Chan, Jamie and El Kurdi, Abdullah and Rahim, Maha and Kondo, Ayano and Han, David and Ali, Hira and D'Angio, Blaize and Mayer, Aaron and Klufas, Daniel and Kim, Esther and Shain, A Hunter and Choi, Jaehyuk and Bhutani, Tina and Simpson, Gregory and Grekin, Roy C and Ricardo-Gonzalez, Roberto and Purdom, Elizabeth and North, Jeffrey P and Cheng, Jeffrey B and Cho, Raymond J},
title = {A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {91},
doi = {10.1126/sciimmunol.adi2848}
}
EUVIMED